1 November 2023 v2025.31.1 micro_entity_frs_105_v1_1_2 filingSoftwarefalsetruetruetruefalseNo description of principal activity0truexbrli:purexbrli:sharesiso4217:GBP144533292023-11-012024-10-31144533292024-10-31144533292023-10-3114453329bus:RegisteredOffice2023-11-012024-10-3114453329bus:Director12023-11-012024-10-311445332912023-11-012024-10-31144533292022-11-012023-10-3114453329countries:EnglandWales2023-11-012024-10-3114453329bus:AuditExemptWithAccountantsReport2023-11-012024-10-3114453329bus:PrivateLimitedCompanyLtd2023-11-012024-10-3114453329bus:Micro-entities2023-11-012024-10-3114453329bus:FullAccounts2023-11-012024-10-31
Company registration number:
14453329
Pharmasight Consulting Limited
Unaudited Filleted Financial Statements for the year ended
31 October 2024
Pharmasight Consulting Limited
Statement of Financial Position
31 October 2024
20242023
££
Fixed assets -  
498
 
   
Current assets
1,160
 
861
 
Net current assets
1,160
 
861
 
Total assets less current liabilities
1,160
 
1,359
 
Accruals and deferred income
(1,200
) -  
Net (liabilities)/assets
(40
)
1,359
 
   
Capital and reserves
(40
)
1,359
 

Notes to the Financial Statements

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
32 Morden House, London Road, Morden
,
Morden
,
Surrey
,
SM4 5HH
, United Kingdom.

2 Average number of employees

The average number of persons employed by the company during the year was
1
(2023: nil).
For the year ending
31 October 2024
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
7 May 2025
, and are signed on behalf of the board by:
S Choudhury
Director
Company registration number:
14453329